| |
| |
|
| Insider
Information: |
Fluke John M Jr |
| Relationship: |
Director |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
179,199 |
|
|
Indirect Shares
|
6,731 |
|
|
| Direct
Value |
$2,941,875 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
185,930 |
|
|
| Total
Value |
$2,941,875 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Paccar Inc |
PCAR |
Director |
2010-10-29 |
25,315 |
2003-03-06 |
0 |
Premium* |
|
|
Cti Biopharma Corporation |
CTIC |
Director |
2005-03-14 |
10,000 |
2005-03-14 |
0 |
Premium* |
|
|
Athira Pharma, Inc. |
ATHA |
Director |
2021-02-03 |
143,884 |
2021-02-03 |
6,731 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATHA |
Athira Pharma, Inc. |
Director |
– • – |
2021-02-03 |
4 |
OE |
$1.19 |
$35,119 |
D/D |
29,003 |
143,884 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Director |
– • – |
2020-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
6,731 |
6,731 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Director |
– • – |
2020-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
64,441 |
114,881 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Director |
– • – |
2020-09-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,440 |
|
- |
|
| PCAR |
Paccar Inc |
Director |
– • – |
2010-10-29 |
4 |
S |
$51.00 |
$153,000 |
D/D |
(3,000) |
25,315 |
0 |
- |
|
| PCAR |
Paccar Inc |
Director |
– • – |
2010-10-27 |
4 |
GD |
$50.88 |
$2,391 |
D/D |
47 |
28,315 |
0 |
- |
|
| PCAR |
Paccar Inc |
Director |
– • – |
2010-07-30 |
4 |
S |
$44.80 |
$134,400 |
D/D |
(3,000) |
28,362 |
0 |
- |
|
| PCAR |
Paccar Inc |
Director |
– • – |
2010-01-04 |
4 |
A |
$36.61 |
$90,024 |
D/D |
2,459 |
31,362 |
0 |
- |
|
| PCAR |
Paccar Inc |
Director |
– • – |
2009-01-02 |
4 |
A |
$30.88 |
$90,015 |
D/D |
2,915 |
28,903 |
0 |
- |
|
| PCAR |
Paccar Inc |
Director |
– • – |
2008-01-02 |
4 |
A |
$52.98 |
$90,013 |
D/D |
1,699 |
25,988 |
0 |
- |
|
| PCAR |
Paccar Inc |
Director |
– • – |
2007-01-03 |
4 |
A |
$64.91 |
$90,030 |
D/D |
1,387 |
16,193 |
0 |
- |
|
| PCAR |
Paccar Inc |
officerTitle |
– • – |
2006-01-03 |
4 |
A |
$70.35 |
$90,048 |
D/D |
1,280 |
9,871 |
|
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2005-03-14 |
4 |
B |
$4.00 |
$20,000 |
D/D |
5,000 |
10,000 |
2.39 |
- |
|
| PCAR |
Paccar Inc |
Director |
– • – |
2005-01-03 |
4 |
A |
$78.83 |
$60,068 |
D/D |
762 |
8,591 |
|
- |
|
| PCAR |
Paccar Inc |
Director |
– • – |
2004-04-27 |
4 |
A |
$55.95 |
$49,963 |
D/D |
893 |
7,829 |
|
- |
|
| PCAR |
Paccar Inc |
Director |
– • – |
2004-01-02 |
4 |
A |
$83.92 |
$10,070 |
D/D |
120 |
4,625 |
|
- |
|
| PCAR |
Paccar Inc |
Director |
– • – |
2003-11-11 |
4 |
S |
$73.83 |
$154,841 |
D/D |
(2,097) |
4,505 |
|
- |
|
| PCAR |
Paccar Inc |
Director |
– • – |
2003-09-08 |
4 |
A |
$84.72 |
$525 |
D/D |
6 |
6,602 |
|
- |
|
| PCAR |
Paccar Inc |
Director |
– • – |
2003-06-06 |
4 |
A |
$70.75 |
$524 |
D/D |
7 |
6,596 |
|
- |
|
| PCAR |
Paccar Inc |
Director |
– • – |
2003-03-06 |
4 |
A |
$46.49 |
$474 |
D/D |
10 |
6,588 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
